THEOCLEAR-100 |
DIMETHYLXANTHINE |
AEROLATE SR |
NUELIN SA-250 |
LABID |
NUELIN SA |
UNIPHYL |
T-PHYL |
SOMOPHYLLIN-CRT |
UNIPHYLLIN CONTINUS |
AEROLATE III |
ELIXOMIN |
PRO-VENT |
SLO-BID |
THEOCLEAR-80 |
SUSTAIRE |
AEROLATE |
SOMOPHYLLIN-T |
THEOLAIR-SR |
THEOCLEAR L.A.-130 |
THEOCLEAR-200 |
THEOPHYL |
NSC-2066 |
THEOPHYL-SR |
LANOPHYLLIN |
UNI-DUR |
THEOGRAD |
THEOPHYL-225 |
QUIBRON-T |
BRONKODYL |
THEOPHYLLINE MONOHYDRATE |
QUIBRON |
LASMA |
THEOCLEAR L.A.-260 |
ELIXOPHYLLIN |
THEOLAIR |
THEOBID JR. |
QUIBRON-T/SR |
THEOLIXIR |
SLO-PHYLLIN |
NUELIN |
THEOVENT |
THEOCHRON |
AEROLATE JR |
RESPBID |
ACCURBRON |
THEOPHYLLINE |
THEOPHYLLINE MELTING POINT STANDARD |
THEOBID |
THEO-24 |
ELIXICON |
THEOCIN |
DURAPHYL |
THEO-DUR |
THEOPHYLLINE-SR |
AQUAPHYLLIN |
ELIXOPHYLLIN SR |
THEACITIN |
UNIFYL |
SYNOPHYLATE-L.A. CENULES |
SLO-BID® |
THEOCLEAR 80 |
AMINOPHYLLINE |
TEFAMIN |
PSEUDOTHEOPHYLLINE |
AUSTYN |
ACET-THEOCIN |
MEDAPHYLLIN |
THEOPHYLLINE, ANHYDROUS |
TEOFYLLAMIN |
EUPHYLONG |
DIPHYLLIN |
THEOFOL |
UNIPHYLLIN |
XANTHIUM |
ELIXEX |
SOLOSIN |
SYNOPHYLATE |
TEOLAIR |
THEOCLEAR LA |
THEOSTAT 80 |
MAPHYLLINE |
THEAL TABLETS |
THEOPHYLLINE ANHYDROUS |
TEOFILINA |
THEOCLAIR-SR |
1,3-DIMETHYL-7H-PURINE-2,6-DIONE |
OPTIPHYLLIN |
DORAPHYLLIN |
NUELIN® |
PARKOPHYLLIN |
ELIXOPHYLLINE |
THEOPHYLLIN |
ASBRON |
THEAL TABL. |
THEO-DUR-SPRINKLE |
BRONKODYL SR |
QUIBRON T/SR |
SOMOPHYLLIN-DF |
THEODEL |
DYSPNE-INHAL |
ASMAX |
LIQUOPHYLLINE |
THEOLIX |
ARMOPHYLLINE |
THEOLAIR® |
THEONA P |
CHOLEDYL SA |
XANTIVENT |
SPOPHYLLIN RETARD |
THEOPHYLINE |
1,3-DIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE |
THEOCONTIN |
EUPHYLLINE |
CONSTANT-T |
1,3-DIMETHYLXANTHINE |
chembl:CHEMBL190 |
pubchem.compound:2153 |
chemidplus:58-55-9 |
drugbank:00277 |
rxcui:91178 |
Year of Approval | approved before 1982 |
Drug Class | bronchodilator agents |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | bronchodilator |
antagonist (inhibitory) |
Trial Name | ADC4022, low-dose inhaled theophylline |
Novel drug target | Established target |
Mechanism of Interaction | Adenosine receptor antagonist |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Phosphodiesterase 3 inhibitor |
Trial Name | ADC4022, low-dose inhaled theophylline |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | ADC4022, low-dose inhaled theophylline |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
antagonist (inhibitory) |
Trial Name | ADC4022, low-dose inhaled theophylline |
Novel drug target | Established target |
Mechanism of Interaction | Adenosine receptor antagonist |
inhibitor (inhibitory) |
Trial Name | ADC4022, low-dose inhaled theophylline |
Novel drug target | Established target |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 3 inhibitor |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Adenosine receptor antagonist |
Direct Interaction | yes |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | ADC4022, low-dose inhaled theophylline |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
antagonist (inhibitory) |
Mechanism of Interaction | Adenosine receptor antagonist |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Phosphodiesterase 4 inhibitor |
Direct Interaction | yes |
THEOPHYLLINE | Primary Drug Name |
Drug Class | bronchodilator agents |
Year of Approval | approved before 1982 |
Drug Indications | bronchodilator |
Drug Class | Small Molecule |
FDA Approval | approved |
C872 | NCI drug code |
CHEMBL190 | ChEMBL Drug ID |
D0F8RA | TTD Drug ID |